Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis - Proteomic patterns of joint inflammation in early stage disease

Journal of Proteomics

Volumn 72, Issue 4, 2009, Pages 656-676

  Gibson, David S ^a   Blelock, Sarah ^a   Curry, Jim ^a   Finnegan, Sorcha ^a   Healy, Adrienne ^a   Scaife, Caitriona ^b   McAllister, Catherine ^a   Pennington, Stephen ^b   Dunn, Michael ^b   Rooney, Madeleine ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Inflammation; Juvenile arthritis; Proteomics; Synovial fluid

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C3; PREALBUMIN; PROTEOME; SERUM ALBUMIN; TRANSFERRIN;

ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; SYNOVIAL FLUID; TWO DIMENSIONAL FLUORESCENCE DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; JOINTS; MALE; MOLECULAR SEQUENCE DATA; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SYNOVIAL FLUID;

EID: 63649103809     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.01.022     Document Type: Article

References (45)

1. Symmons D.P., Jones M., Osborne J., Sills J., Southwood T.R., and Woo P. Pediatric rheumatology in the united kingdom: data from the British pediatric rheumatology group national diagnostic register. J Rheumatol 23 (1996) 1975-1980
2. Manners P.J., and Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much?. J Rheumatol 29 (2002) 1520-1530
3. Flato B., Sorskaar D., Vinje O., Lien G., Aasland A., Moum T., et al. Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood health assessment questionnaire. J Rheumatol 25 (1998) 1851-1858
4. Flato B., Lien G., Smerdel A., Vinje O., Dale K., Johnston V., et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 30 (2003) 386-393
5. Huemer C., Malleson P.N., Cabral D.A., Huemer M., Falger J., Zidek T., et al. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. J Rheumatol 29 (2002) 1531-1535
6. Hii C.S., Marin L.A., Halliday D., Roberton D.M., Murray A.W., and Ferrante A. Regulation of human neutrophil-mediated cartilage proteoglycan degradation by phosphatidylinositol-3-kinase. Immunology 102 (2001) 59-66
7. de Kleer I.M., Wedderburn L.R., Taams L.S., Patel A., Varsani H., Klein M., et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172 (2004) 6435-6443
8. Khalkhali-Ellis Z., Seftor E.A., Nieva D.R., Seftor R.E., Samaha H.A., Bultman L., et al. Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population. J Rheumatol 24 (1997) 2451-2460
9. Foell D., Frosch M., Schulze zur Wiesch A., Vogl T., Sorg C., and Roth J. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?. Ann Rheum Dis 63 (2004) 206-208
10. Uhl M., Krauss M., Kern S., Herget G., Hauer M.P., Altehoefer C., et al. The knee joint in early juvenile idiopathic arthritis. Acta Radiol 42 (2001) 6-9
11. Honkanen V.E., Rautonen J.K., and Pelkonen P.M. Intra-articular glucocorticoids in early juvenile chronic arthritis. Acta Paediatr 82 (1993) 1072-1074
12. Blelock S., McAllister C., Gibson D., Clarke S., and Rooney M. Juvenile idiopathic arthritis: joint destruction vs joint repair. clinical and histological findings in early untreated disease. Arthritis Rheum 54 (2006) S692
13. Gibson D.S., Blelock S., Brockbank S., Curry J., Healy A., McAllister C., et al. Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis. J Proteome Res 5 (2006) 1988-1995
14. Frosch M., Vogl T., Seeliger S., Wulffraat N., Kuis W., Viemann D., et al. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 48 (2003) 2622-2626
15. Gibson D.S., and Rooney M. The human synovial fluid proteome: a key factor in the pathology of joint disease. Proteomics Clin Appl 1 (2007) 889-899
16. Rifai N., Gillette M.A., and Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24 (2006) 971-983
17. Shevchenko A., Tomas H., Havlis J., Olsen J.V., and Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1 (2006) 2856-2860
18. Pappin D.J., Hojrup P., and Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3 (1993) 327-332
19. Sinz A., Bantscheff M., Mikkat S., Ringel B., Drynda S., Kekow J., et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23 (2002) 3445-3456
20. Park Y.B., Lee S.K., Lee W.K., Suh C.H., Lee C.W., Lee C.H., et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26 (1999) 1701-1704
21. Doherty N.S., Littman B.H., Reilly K., Swindell A.C., Buss J.M., and Anderson N.L. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 19 (1998) 355-363
22. Ananth L., Prete P.E., and Kashyap M.L. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism 42 (1993) 803-806
23. Busso N., Dudler J., Salvi R., Peclat V., Lenain V., Marcovina S., et al. Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol 159 (2001) 1445-1453
24. Bresnihan B., Gogarty M., FitzGerald O., Dayer J.M., and Burger D. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?. Arthritis Res Ther 6 (2004) R563-R566
25. Hyka N., Dayer J.M., Modoux C., Kohno T., Edwards III C.K., Roux-Lombard P., et al. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97 (2001) 2381-2389
26. Burger D., and Dayer J.M. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res 4 Suppl 3 (2002) S169-S176
27. Wan J., Sun W., Li X., Ying W., Dai J., Kuai X., et al. Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 6 (2006) 2886-2894
28. Mikkat S., Koy C., Ulbrich M., Ringel B., and Glocker M.O. Mass spectrometric protein structure characterization reveals cause of migration differences of haptoglobin alpha chains in two-dimensional gel electrophoresis. Proteomics 4 (2004) 3921-3932
29. Hu Y., Malone J.P., Fagan A.M., Townsend R.R., and Holtzman D.M. Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol Cell Proteomics 4 (2005) 2000-2009
30. Muller-Eberhard H.J., and Schreiber R.D. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 29 (1980) 1-53
31. Schwaeble W., Huemer H.P., Most J., Dierich M.P., Strobel M., Claus C., et al. Expression of properdin in human monocytes. Eur J Biochem 219 (1994) 759-764
32. Wirthmuller U., Dewald B., Thelen M., Stover C., Schafer M.K., Whaley K., et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 158 (1997) 4444-4451
33. Levick J.R. A method for estimating macromolecular reflection by human synovium, using measurements of intra-articular half lives. Ann Rheum Dis 57 (1998) 339-344
34. Gaffney K., Cookson J., Blades S., Coumbe A., and Blake D. Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging. Ann Rheum Dis 57 (1998) 152-157
35. Levick J.R., and McDonald J.N. Fluid movement across synovium in healthy joints: role of synovial fluid macromolecules. Ann Rheum Dis 54 (1995) 417-423
36. Sabaratnam S., Arunan V., Coleman P.J., Mason R.M., and Levick J.R. Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints. J Physiol 567 (2005) 569-581
37. Oettl K., and Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151 (2007) 580-590
38. Gobezie R., Kho A., Krastins B., Sarracino D.A., Thornhill T.S., Chase M., et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 9 (2007) R36
39. Kamphorst J.J., Heijden R.V., Degroot J., Lafeber F.P., Reijmers T.H., El B.V., et al. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: Method validation and peptide identification. J Proteome Res 6 (2007) 4388-4396
40. Goncalves A., Esterni B., Bertucci F., Sauvan R., Chabannon C., Cubizolles M., et al. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 25 (2006) 981-989
41. Chen J.H., Chang Y.W., Yao C.W., Chiueh T.S., Huang S.C., Chien K.Y., et al. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A 101 (2004) 17039-17044
42. Fairney A., Straffen A.M., May C., and Seifert M.H. Vitamin D metabolites in synovial fluid. Ann Rheum Dis 46 (1987) 370-374
43. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50 (2004) 3792-3803
44. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., Schneider P., and Tissot J.D. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
45. Glocker M.O., Guthke R., Kekow J., and Thiesen H.J. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 26 (2006) 63-87